Chris Mansi, MD, is CEO and Co-Founder of Viz.ai, the leader in AI-powered disease detection and care coordination. Today, the Viz.ai One Platform has 30 care pathways, is adopted in more than 1,700 hospitals, and collaborates with seven of the leading, global pharmaceutical and medical device companies, improving access to life-saving treatments for more than 230 million people.
Dr. Mansi co-founded Viz.ai out of Stanford in 2016 with a mission of using artificial intelligence to increase access to life-saving treatments. Under his leadership, Viz.ai has achieved several AI industry milestones, including two de novo approvals by the FDA for AI computer–aided triage in 2018 and cardiovascular machine learning-based notification software in 2023. Viz.ai was also the first AI company to be granted CMS reimbursement via the New Technology Add-on Payment (NTAP) for AI in 2020.
